AGE RECODE INSIGHTS

Peptide Science and Practice Growth, Explained.

Clinical education and business strategy for providers building a peptide revenue line.

Physician in a white coat smiling with an older patient during a peptide therapy consultation in a bright clinic

GLP-1s Are Just the Beginning: The Peptide Categories Patients Are Asking About

GLP-1s opened the door. Here are the five peptide categories patients are asking about next: metabolic, recovery, cognitive, longevity, and cosmetic.

June 10, 2026•7 min read

Physician practice owner reviewing growth metrics on a tablet at the front desk of a modern medical practice

Practice Revenue

How Practices Build a Six-Figure Peptide Revenue Line (Without Billing Insurance)

Peptides are a cash-pay program, not an insurance service. Here is where the revenue actually comes from: initial protocols, monthly reorders, and multi-product stacks.

July 15, 2026•8 min read

Glowing cyan pharmaceutical vials in a dark cleanroom laboratory

Compliance

Peptide Sourcing 101: What cGMP, ISO-7, and Third-Party Verification Actually Mean

How to evaluate a peptide supplier before you put your license and reputation behind one.

May 28, 2026•9 min read

Physician reviewing a structured treatment plan with a patient during a consultation in a modern clinic

Clinical

Starting Patients on Peptides: A Clinical Framework for the First 90 Days

Patient selection, informed consent, protocol choice, and follow-up. A practical framework for adding peptides to patient care responsibly.

August 17, 2026•9 min read

Female physician in a white coat reviewing AgeREcode enteric-coated oral peptide capsules at a clinic desk with laptop, representing needle-free peptide therapy for medical practices

Product Science

Oral Peptides vs. Injections: How Enteric-Coated Capsules Deliver Peptides Without a Needle

Most peptides break down in the stomach, which is why they are injected. How enteric-coated capsules and topical serums deliver peptides without a needle.

August 26, 2026•8 min

Compliance

Research Use Only vs. Compounded vs. FDA-Approved: The Three Regulatory Lanes for Peptides in Your Practice

Peptides reach a practice through three regulatory lanes: FDA-approved, 503A or 503B compounded, and Research Use Only. What each lane means for how you operate.

September 3, 2026•9 min

Ready to Build Your Peptide Revenue Line?

Apply for wholesale access. Get pricing, sample kits, and full clinical support.

Apply Now Order Form